Voya VP International Index Portfolio I (IIIIX)
11.61
+0.28
(+2.47%)
USD |
Apr 11 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.45% | 1.116B | 2.68% | 7.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -80.86M | 3.47% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Portfolio seeks results that correspond to the total return of the Morgan Stanley Capital International Europe, Australia and Far East Index which is a market value-weighted index that reflects the performance of approximately 1,100 securities listed on the stock exchanges of Europe, Australasia and the Far East. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Voya |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
80
-1.638B
Peer Group Low
1.274B
Peer Group High
1 Year
% Rank:
64
-80.86M
-4.738B
Peer Group Low
4.559B
Peer Group High
3 Months
% Rank:
70
-5.875B
Peer Group Low
2.011B
Peer Group High
3 Years
% Rank:
68
-8.170B
Peer Group Low
12.66B
Peer Group High
6 Months
% Rank:
67
-5.915B
Peer Group Low
4.122B
Peer Group High
5 Years
% Rank:
72
-18.36B
Peer Group Low
26.60B
Peer Group High
YTD
% Rank:
69
-5.875B
Peer Group Low
2.011B
Peer Group High
10 Years
% Rank:
80
-28.94B
Peer Group Low
37.73B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of April 12, 2025.
Asset Allocation
As of February 28, 2025.
| Type | % Net |
|---|---|
| Cash | 1.85% |
| Stock | 96.89% |
| Bond | 0.87% |
| Convertible | 0.00% |
| Preferred | 0.34% |
| Other | 0.05% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
MSCI EAFE MAR5
|
3.18% | -- | -- |
| Morgan Stanley Inst Liq Govt Port Institutional | 1.92% | 1.00 | 0.00% |
| Novo Nordisk AS | 1.64% | 64.44 | 5.47% |
| SAP SE | 1.63% | 257.42 | -0.22% |
| ASML Holding NV | 1.59% | 668.21 | 3.28% |
| Nestle SA | 1.42% | 104.50 | 3.30% |
| AstraZeneca PLC | 1.32% | 132.68 | 2.92% |
| Roche Holding AG | 1.31% | 304.24 | 2.94% |
| HSBC Holdings PLC | 1.21% | 9.25 | -1.49% |
| Novartis AG | 1.20% | 104.15 | 1.66% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.33% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product |
|
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 0.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Portfolio seeks results that correspond to the total return of the Morgan Stanley Capital International Europe, Australia and Far East Index which is a market value-weighted index that reflects the performance of approximately 1,100 securities listed on the stock exchanges of Europe, Australasia and the Far East. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Voya |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (4-11-25) | 2.82% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 23.20 |
| Weighted Average Price to Sales Ratio | 3.768 |
| Weighted Average Price to Book Ratio | 4.297 |
| Weighted Median ROE | 16.95% |
| Weighted Median ROA | 6.17% |
| ROI (TTM) | 11.14% |
| Return on Investment (TTM) | 11.14% |
| Earning Yield | 0.0605 |
| LT Debt / Shareholders Equity | 0.7678 |
As of February 28, 2025
Growth Metrics
| EPS Growth (1Y) | 13.69% |
| EPS Growth (3Y) | 14.21% |
| EPS Growth (5Y) | 9.94% |
| Sales Growth (1Y) | 5.67% |
| Sales Growth (3Y) | 9.37% |
| Sales Growth (5Y) | 6.54% |
| Sales per Share Growth (1Y) | 7.53% |
| Sales per Share Growth (3Y) | 10.69% |
| Operating Cash Flow - Growth Ratge (3Y) | 8.53% |
As of February 28, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:IIIIX", "name") |
| Broad Asset Class: =YCI("M:IIIIX", "broad_asset_class") |
| Broad Category: =YCI("M:IIIIX", "broad_category_group") |
| Prospectus Objective: =YCI("M:IIIIX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |